Construction of the ceRNA network in the progression of acute myocardial infarction

Hui Liu1, Shuai Qin1, Yuanyuan Zhao1

  • 1Department of Cardiovascular Surgery, Linfen Central Hospital Linfen, Shanxi, China.

Insights

This study reveals a circRNA-miRNA-mRNA network crucial for acute myocardial infarction (AMI) progression, identifying key immune-related genes and circRNAs that could inform new therapeutic strategies for this widespread cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Genomics

Background:

  • Acute myocardial infarction (AMI) presents a significant global health burden.
  • Noncoding RNAs, including circRNAs, lncRNAs, and miRNAs, are implicated in cardiovascular disease pathogenesis.
  • The specific circRNA-miRNA-mRNA regulatory network in AMI requires further elucidation.

Purpose of the Study:

  • To investigate the circRNA-miRNA-mRNA network involved in the occurrence and development of AMI.
  • To identify key regulatory molecules and pathways contributing to AMI pathology.
  • To provide insights for potential therapeutic strategies for AMI.

Main Methods:

  • Downloaded and analyzed circRNA, miRNA, and mRNA expression datasets for AMI from the GEO database.
  • Utilized RStudio for differential expression analysis and Gene Ontology (GO) and KEGG pathway enrichment.
  • Employed Protein-Protein Interaction (PPI) networks and Cytoscape for hub gene identification and constructed the ceRNA network using starbase and circinteractome databases.

Main Results:

  • Identified 46 differentially expressed mRNAs, 65 miRNAs, and five circRNAs associated with AMI.
  • GO and KEGG analyses highlighted immune response pathways, including IL-17, Toll-like receptor, TNF, chemokine, and NF-kappaB signaling.
  • Discovered 10 hub genes (e.g., TLR2, IL1B, CCL4, CCL20) and identified circRNA_023461 and circRNA_400027 as key regulators in the circRNA-miRNA-mRNA network.

Conclusions:

  • Uncovered a novel circRNA-miRNA-mRNA regulatory network in AMI.
  • Demonstrated the involvement of immune-related genes and pathways in AMI progression.
  • Highlighted circRNA_023461 and circRNA_400027 as potential therapeutic targets for improving AMI treatment strategies.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
49
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
26
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
18